A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Alberto Fragasso Roberto Guariglia Luigi Marcheselli Gruppo Italiano Studio Linfomi (GISL) Angelo Michele Carella Alessia Bari Samantha Pozzi Raffaella Marcheselli Paola Ferri Caterina Stelitano Francesco Angrilli Luca Baldini Santo Neri |
| Publication date | November 4, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |